Pathologic effects of testosterone deprivation.

Pathologic effects of testosterone deprivation.

Item
http://www.wikidata.org/entity/Q36964257
Mortality following hip fracture in men with prostate cancer.Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.Tissue-selective regulation of androgen-responsive genesIntraperitoneal administration of gonadotropin-releasing hormone-PE40 induces castration in male ratsEnhanced evaluation of selective androgen receptor modulators in vivo.Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.Association of serum calcium with serum sex steroid hormones in men in NHANES III.Improving selective androgen receptor modulator discovery and preclinical evaluation.Effect of androgen deprivation therapy on cardiovascular risk factors in prostate cancerAndrogen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein.The language of prostate cancer treatments and implications for informed decision making by patients.
P2860

Pathologic effects of testosterone deprivation.

Item
http://www.wikidata.org/entity/Q36964257
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pathologic effects of testosterone deprivation.
@en
type
label
Pathologic effects of testosterone deprivation.
@en
prefLabel
Pathologic effects of testosterone deprivation.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Pathologic effects of testosterone deprivation.
@en
P2093
P304
P31
P356
10.1097/MOU.0B013E3282F0EBEF
P433
P478
P577
P698